CME Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
1.7B
+1.8%
1.7B
-9.2%
1.9B
+14.0%
1.6B
+7.2%
1.5B
Cost of Revenue
0
0
0
0
0
Gross Profit
1.7B
+1.8%
1.7B
-9.2%
1.9B
+14.0%
1.6B
+7.2%
1.5B
Operating Expenses
595.9M
-0.5%
599.1M
+5.0%
570.4M
-9.3%
629.1M
+11.3%
565.0M
R&D
0
-100.0%
83.3M
0
0
0
SG&A
346.3M
+31.9%
262.6M
-19.9%
327.8M
-10.0%
364.2M
+5.4%
345.7M
Operating Income
1.1B
+3.1%
1.1B
-15.5%
1.3B
+28.5%
1.0B
+4.8%
972.6M
EBITDA
1.2B
+2.8%
1.2B
-14.5%
1.4B
+26.4%
1.1B
+4.4%
1.1B
Net Income
1.0B
-0.5%
1.0B
-9.7%
1.2B
-2.4%
1.2B
+30.3%
908.0M
EPS (Basic)
$2.90
+0.3%
$2.89
-11.1%
$3.25
+0.0%
$3.25
+30.5%
$2.49
EPS (Diluted)
$2.89
+0.3%
$2.88
-9.4%
$3.18
-1.9%
$3.24
+30.1%
$2.49
Shares (Diluted)
358.6M
-0.7%
361.3M
-0.5%
363.2M
+0.8%
360.2M
-0.1%
360.4M
CME (CME) — Financials